Multidrug resistant tinea corporis/cruris: Response to voriconazole - 12/11/22
Abstract |
The increasing worldwide resistance to terbinafine and older antifungal drugs, coupled with often erratic clinical responses to itraconazole, leaves dermatologists with limited options to deal with dermatophytic infections. Recalcitrant dermatophytoses has however, over past few years, become a significant public health issue, especially in India. In this context, we present a patient who failed four systemic antifungals sequentially and was subsequently cured with a 2 week course of voriconazole, an antifungal not routinely used for dermatophytoses as yet.
Le texte complet de cet article est disponible en PDF.Keywords : Resistance, Dermatophytes, Voriconazole, Tinea corporis cruris, Itraconazole, terbinafine
Vol 32 - N° 4
Article 101306- novembre 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?